Immutep (ASX:IMM) has announced promising new data from its Phase IIb TACTI-003 trial, presented at the ESMO Immuno-Oncology Congress 2024.

A cutting-edge study has uncovered crucial new insights into the effects of equatorial plasma bubbles (EPBs) on aircraft ...

US stocks surged overnight, with the Nasdaq Composite closing above 20,000 for the first time. Latest US CPI data boosts rate cut expectations.